slide bottom shade

Promoting Effective Mastitis Treatment in Dairy Cattle: A Step Toward Better Animal Health and Productivity

Mastitis is one of the most common yet under-addressed diseases in dairy cows in Bangladesh. For families relying on dairy farming, this condition quietly chips away at livelihoods—causing sickness in cows, lowering milk quality, and reducing income. Despite ongoing efforts to boost milk production, untreated or poorly treated mastitis continues to cause long-term health damage and economic loss.

The problem often starts with misdiagnosis or delayed treatment. Many farmers rely only on visible signs—like swollen udders or clotted milk—and start using antibiotics without veterinary advice. This not only reduces the chances of recovery but also increases the risk of antimicrobial resistance (AMR), a growing threat to both animal and human health. In rural areas, limited access to skilled Veterinary practitioners and diagnostic tools worsens the situation. Studies show that mastitis prevalence in Bangladesh ranges from 19.9% to 42.7%, with subclinical cases being 15 to 40 times more common than clinical ones. Sahiwal crosses (47.4%) and Holstein Friesians (39.7%) show higher susceptibility than native breeds (37.6%), especially during the wet season and mid to late lactation.

Early detection is key to successful mastitis management. Tests like the California Mastitis Test (CMT) and Somatic Cell Count (SCC) help to detect subclinical mastitis before symptoms appear, though confirming the infection often requires lab-based bacterial culture. Once identified, treatment should be guided by veterinarians, with intramammary antibiotics infusion often preferred for its effectiveness.

ACI Animal Health has commitment to cattle health through innovative solutions is evident and recently join hands with renowned company Syva, Spain to introduce intramammary infusion as a targeted treatment for bovine mastitis in Bangladesh. It's crucial to follow the correct dosage and duration, and to observe withdrawal periods to keep milk safe. Annual economic losses from mastitis in Bangladesh are estimated at Tk. 122.6 million, with each clinical case costing up to Tk. 42,412 due to treatment, milk loss, and even calf deaths.

While antibiotics remain central to treatment, preventive practices—such as post-milking teat dipping, improved milking hygiene, balanced nutrition, and immune boosters—can reduce recurrence and improve outcomes. For smallholder farmers, effective mastitis management isn’t just about healthy cows. It’s about sustaining incomes, ensuring safer milk, and building a more resilient dairy sector. A national approach that includes awareness programs, regular screening, and proper treatment is essential to move forward.

Dr. F H Ansarey President ACI Agribusinesses Division